The data presented show that a low FFMI and weakness in COPD patients are associated with increased expression of miR‐675 and H19 in the muscle and that muscle weakness correlates in these patients with relative methylation of the H19 ICR. Here, H19 is linked to chronic obstructive pulmonary disease.